Healthcare -
Biotechnology - NASDAQ - US
$ 1.65
-1.2 %
$ 51.2 M
Market Cap
-0.84
P/E
IMRX - GROSS PROFIT
Gross Profit IMRX - Immuneering Corporation
-764 K
LAST VALUE
-35.07%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR